There has been a secret initiative by Apple that has started by hiring a team of biomedical engineers as part of a project for fight against Diabetes. Initially, the idea was envisioned by late Apple co-founder Steve Jobs, to develop sensors to treat diabetes.
An Apple spokeswoman declined to comment on the subject.
There is information’s that the engineers are expected to work at a nondescript office in Palo Alto, California, close to the corporate headquarters.
It’s more and more obvious that the time has come when the line between pharmaceuticals and technology is blurring as companies are joining forces to tackle chronic diseases using high-tech devices that combine biology, software and hardware, thereby jump-starting a novel field of medicine called bioelectronics.
Just last year, we were witnesses of this kind of joint venture between GlaxoSmithKline and Google to parent Alphabet and unveil a joint company aimed at marketing bioelectronics devices to fight illness by attaching to individual nerves.
Also, another example is US biotech firms Setpoint Medical and EnteroMedics who have already shown early benefits of bioelectronics in treating rheumatoid arthritis and suppressing appetite in the obese.
Other companies playing around the idea of bioelectronics include Medtronic, Proteus Digital Technology, Sanofi and Biogen.